226 related articles for article (PubMed ID: 14984584)
1. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
[TBL] [Abstract][Full Text] [Related]
2. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
3. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
4. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
Cai JP; Randall B
J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
[No Abstract] [Full Text] [Related]
5. Aberrant tyrosinase expression in an atypical fibroxanthoma: A case report.
Weiss A; Vanchinathan V; Kwon EJ
J Cutan Pathol; 2017 May; 44(5):467-469. PubMed ID: 28097678
[TBL] [Abstract][Full Text] [Related]
6. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
7. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Melan-A expression in atypical fibroxanthoma and undifferentiated pleomorphic sarcoma of the skin.
Thum C; Hollowood K; Birch J; Goodlad JR; Brenn T
J Cutan Pathol; 2011 Dec; 38(12):954-60. PubMed ID: 22050092
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
10. [A rare low-grade malignant scalp tumor. Atypical fibroxanthoma].
Stepanova A; Marsch WC; Stadie V
Hautarzt; 2005 Jul; 56(7):679-82. PubMed ID: 15726303
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
12. Clear cell atypical fibroxanthoma - report of a case with review of the literature.
Murali R; Palfreeman S
J Cutan Pathol; 2006 May; 33(5):343-8. PubMed ID: 16640540
[TBL] [Abstract][Full Text] [Related]
13. Pigmented atypical fibroxanthoma.
Diaz-Cascajo C; Borghi S; Bonczkowitz M
Histopathology; 1998 Dec; 33(6):537-41. PubMed ID: 9870148
[TBL] [Abstract][Full Text] [Related]
14. Recurrent atypical fibroxanthoma of the cheek.
Skoulas IG; Price M; Andrew JE; Kountakis SE
Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis: atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach.
Heintz PW; White CR
Semin Cutan Med Surg; 1999 Mar; 18(1):78-83. PubMed ID: 10188846
[TBL] [Abstract][Full Text] [Related]
17. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
Jensen K; Wilkinson B; Wines N; Kossard S
J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical study.
Ito A; Yamada N; Yoshida Y; Morino S; Yamamoto O
J Cutan Pathol; 2011 Aug; 38(8):670-6. PubMed ID: 21623865
[TBL] [Abstract][Full Text] [Related]
19. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
20. Granular cell atypical fibroxanthoma: case report and review of the literature.
Wright NA; Thomas CG; Calame A; Cockerell CJ
J Cutan Pathol; 2010 Mar; 37(3):380-5. PubMed ID: 19341433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
